Ilex, MPI Development deal

The companies formed a limited partnership to develop piritrexim, a DNA synthesis inhibitor, to treat

Read the full 150 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE